- Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor2019 | Second Faculty of Medicine
- Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial2018 | Publication without faculty affiliation
- Direct salting-out assisted liquid-liquid extraction (SALLE) from human blood: Application for the analysis of tyrosine kinase inhibitors2020 | Faculty of Science
- Current treatment options for renal cell carcinoma and outlook2020 | Publication without faculty affiliation
- Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia2013 | First Faculty of Medicine
- Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-alpha 2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial2011 | Faculty of Medicine in Hradec Králové
- Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia2015 | Second Faculty of Medicine
- Where does treatment of chronic myeloid leukemia target tyrosine kinase inhibitors?2018 | First Faculty of Medicine
- Survival of patients as a function of MSKCC scores for sunitinib treatment in the 1st mRCC treatment line2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Two years longer and peaceful life thanks to alectinib2022 | Central Library of Charles University, Third Faculty of Medicine
- Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy2024 | Publication without faculty affiliation
- Osimertinib - a new treatment option for patients with EGFR mutation T790M2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission2017 | Publication without faculty affiliation
- Osimertinib - a new oral third-generation EGFR TKI2017 | Publication without faculty affiliation
- Lorlatinib in the treatment of non‑small cell lung cancer2020 | Publication without faculty affiliation
- Lung adenocarcinoma with a rare EGFR mutation and infrequent resistance to treatment2022 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Current position of afatinib in the therapy of non-small cell lung carcinoma2017 | Publication without faculty affiliation
- MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Targeted treatment of NSCLC with kinase inhibitors - afatinib and nintedanib in clinical pracitce2017 | Faculty of Medicine in Pilsen
- Modern diagnosis of lung cancer - a task for close multidisciplinary cooperation2011 | Faculty of Medicine in Hradec Králové
- Interdisciplinary consensus for predictive testing of activation mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer2011 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors2016 | First Faculty of Medicine
- Pilot study on microRNAs as biomarkers of response to sunitinib treatment in patients with metastatic renal cell carcinoma2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Nanomedicine of tyrosine kinase inhibitors2021 | Second Faculty of Medicine, Faculty of Science
- Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine